Shin Ishikane

932 total citations
33 papers, 652 citations indexed

About

Shin Ishikane is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shin Ishikane has authored 33 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shin Ishikane's work include Mesenchymal stem cell research (8 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Cardiac Fibrosis and Remodeling (4 papers). Shin Ishikane is often cited by papers focused on Mesenchymal stem cell research (8 papers), Tissue Engineering and Regenerative Medicine (6 papers) and Cardiac Fibrosis and Remodeling (4 papers). Shin Ishikane collaborates with scholars based in Japan, Türkiye and United States. Shin Ishikane's co-authors include Fumi Takahashi‐Yanaga, Kenji Kangawa, Tomoaki Ikeda, Kenichi Yamahara, Kazuhiko Harada, Katsunori Iwasaki, Michihiro Fujiwara, Hiroshi Hosoda, Kenichi Mishima and Mikiya Miyazato and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Biochemical Pharmacology.

In The Last Decade

Shin Ishikane

28 papers receiving 643 citations

Peers

Shin Ishikane
Shin Ishikane
Citations per year, relative to Shin Ishikane Shin Ishikane (= 1×) peers Wen‐Yu Lin

Countries citing papers authored by Shin Ishikane

Since Specialization
Citations

This map shows the geographic impact of Shin Ishikane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Ishikane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Ishikane more than expected).

Fields of papers citing papers by Shin Ishikane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin Ishikane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Ishikane. The network helps show where Shin Ishikane may publish in the future.

Co-authorship network of co-authors of Shin Ishikane

This figure shows the co-authorship network connecting the top 25 collaborators of Shin Ishikane. A scholar is included among the top collaborators of Shin Ishikane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin Ishikane. Shin Ishikane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arioka, Masaki, Hiroaki Matsunaga, Shin Ishikane, et al.. (2025). Celecoxib inhibits skin fibrosis via suppressing adipocyte progenitor–myofibroblast transdifferentiation by attenuating the YAP/TAZ signaling pathway. Life Sciences. 379. 123914–123914.
2.
Ishikane, Shin, David Back, Fang Zhang, et al.. (2025). Therapeutic mitochondria treatment amplifies macrophage-mediated phagocytosis and recycling exocytosis. Journal of Cerebral Blood Flow & Metabolism. 46(2). 406–417.
3.
Arioka, Masaki, Yi Wang, Kazunobu Igawa, Shin Ishikane, & Fumi Takahashi‐Yanaga. (2024). Differentiation-inducing factor-1 inhibits EMT by proteasomal degradation of TAZ and YAP in cervical and colon cancer cell lines. European Journal of Pharmacology. 987. 177184–177184.
5.
Arioka, Masaki, Koichi Miura, Shin Ishikane, et al.. (2023). Differentiation-inducing factor-1 reduces lipopolysaccharide-induced vascular cell adhesion molecule-1 by suppressing mTORC1-S6K signaling in vascular endothelial cells. Life Sciences. 335. 122278–122278. 2 indexed citations
6.
Takahashi‐Yanaga, Fumi, Shin Ishikane, Hiroshi Hosoda, et al.. (2021). Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells. European Journal of Pharmacology. 909. 174415–174415. 14 indexed citations
7.
Ishikane, Shin, et al.. (2020). Differentiation-inducing factor-1 potentiates adipogenic differentiation and attenuates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(2). 118909–118909. 10 indexed citations
8.
Takahashi‐Yanaga, Fumi, Shin Ishikane, Masaki Arioka, et al.. (2019). 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation. Biochemical Pharmacology. 168. 82–90. 26 indexed citations
9.
Ishikane, Shin & Fumi Takahashi‐Yanaga. (2018). The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis. Biochemical Pharmacology. 151. 96–103. 51 indexed citations
10.
Li, Xiaojia, Takafumi Horishita, Yumiko Toyohira, et al.. (2017). Inhibitory effects of pine nodule extract and its component, SJ-2, on acetylcholine-induced catecholamine secretion and synthesis in bovine adrenal medullary cells. Journal of Pharmacological Sciences. 133(4). 268–275. 1 indexed citations
11.
Kawabe, Shinya, Tetsuya Mizutani, Shin Ishikane, et al.. (2015). Establishment and characterization of a novel orthotopic mouse model for human uterine sarcoma with different metastatic potentials. Cancer Letters. 366(2). 182–190. 8 indexed citations
12.
Kimura, Tōru, Takashi Nojiri, Hiroshi Hosoda, et al.. (2015). Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in Mice. Cancer Chemotherapy and Pharmacology. 75(5). 1057–1063. 13 indexed citations
13.
Kimura, Tōru, Takashi Nojiri, Hiroshi Hosoda, et al.. (2014). C-type natriuretic peptide attenuates lipopolysaccharide-induced acute lung injury in mice. Journal of Surgical Research. 194(2). 631–637. 18 indexed citations
14.
Nojiri, Takashi, Hiroshi Hosoda, Tōru Kimura, et al.. (2014). Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury. Cancer Chemotherapy and Pharmacology. 75(1). 123–129. 17 indexed citations
15.
Mizutani, Tetsuya, Shinya Kawabe, Shin Ishikane, et al.. (2014). Identification of novel steroidogenic factor 1 (SF-1)-target genes and components of the SF-1 nuclear complex. Molecular and Cellular Endocrinology. 408. 133–137. 5 indexed citations
16.
Yamahara, Kenichi, Kazuhiko Harada, Makiko Ohshima, et al.. (2014). Comparison of Angiogenic, Cytoprotective, and Immunosuppressive Properties of Human Amnion- and Chorion-Derived Mesenchymal Stem Cells. PLoS ONE. 9(2). e88319–e88319. 80 indexed citations
17.
Ishikane, Shin, Hiroshi Hosoda, Kenichi Yamahara, et al.. (2013). Allogeneic Transplantation of Fetal Membrane–Derived Mesenchymal Stem Cell Sheets Increases Neovascularization and Improves Cardiac Function after Myocardial Infarction in Rats. Transplantation. 96(8). 697–706. 37 indexed citations
18.
Ishikane, Shin, Kenichi Yamahara, Masaharu Sada, et al.. (2010). Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. Journal of Molecular and Cellular Cardiology. 49(5). 753–761. 24 indexed citations
19.
Ohnishi, Shunsuke, Kazuto Okabe, Hiroaki Obata, et al.. (2009). Involvement of tazarotene‐induced gene 1 in proliferation and differentiation of human adipose tissue‐derived mesenchymal stem cells. Cell Proliferation. 42(3). 309–316. 13 indexed citations
20.
Watanabe, Takuya, Katsunori Iwasaki, Shin Ishikane, et al.. (2008). Spatial Memory Impairment Without Apoptosis Induced by the Combination of Beta-Amyloid Oligomers and Cerebral Ischemia Is Related to Decreased Acetylcholine Release in Rats. Journal of Pharmacological Sciences. 106(1). 84–91. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026